• Academy Events

  • Demyelination and Remyelination: From Mechanism to Therapy

    Thursday, June 26, 2014 | 7:45 AM - 6:00 PM
    The New York Academy of Sciences

    Presented by Acorda Therapeutics and the New York Academy of Sciences

    Demyelinating diseases and disorders affect millions of people worldwide. While multiple sclerosis is the one of the most widely recognized myelin-associated disorders, changes to the brain’s white matter can be found in a number of genetic, inflammatory, infectious, cerebrovascular, and neurodegenerative conditions and injuries. New breakthroughs in basic science research on the white matter microenvironment and oligodendrocyte precursor cell development have provided novel potential sites of action for therapeutics. Translation of these discoveries into biomarkers to predict clinical outcomes, and into biologics that can modulate myelination utilizing these pathways, may transform the treatment of currently incurable conditions.

    This one-day, translational conference will present recent findings in remyelination and repair from disease models and clinical trials, new techniques for imaging myelination changes in the brain and for screening molecular targets, and emerging therapeutics that promote remyelination.

    *Reception to follow.

    Registration Pricing

    By 05/16/2014 After 05/16/2014 Onsite
    Member $100 $125 $150
    Student/Postdoc Member $50 $75 $100
    Nonmember (Academia) $150 $200 $250
    Nonmember (Corporate) $225 $275 $325
    Nonmember (Non-profit) $150 $200 $250
    Nonmember (Student / Postdoc / Fellow) $75 $100 $125


    Paid registration includes a complimentary, one-year membership to the New York Academy of Sciences. Complimentary memberships are provided to non-members only and cannot be used to renew or extend existing or expiring memberships. A welcome email will be sent upon registration which will include your membership credentials.

    Presented by

    • Acorda Therapeutics
    • NYAS

    Supported by

    • Biogen Idec